StockNASDAQ · US · USDTechnology · Software - Application
$APPF
APPFOLIO INC
AppFolio provides a cloud-based platform for property management companies that manage residential, commercial, student, affordable housing, and community association properties. Its platform serves property managers, owners and investors, residents, and vendors, with tools for accounting, reporting, marketing and leasing, maintenance, and communications. AppFolio is headquartered in Santa Barbara, California. The platform is offered through Core, Plus, and Max subscription plans, with additional functionality available as ancillary services. AppFolio also makes money from value-added services, including electronic payments, tenant screening through FolioScreen, risk mitigation through FolioGuard, and resident services. Its AppFolio Stack marketplace supports integrations with third-party technology and services, while AppFolio Realm adds AI features to platform workflows.
Analysts updated ratings and price targets for various U.S. companies. Notable changes include downgrades for 10x Genomics (TXG) and upgrades for Allegion (ALLE). Price targets were raised for AbbVie (ABBV), Amgen (AMGN), and others, while cuts were seen in sectors like retail and housing. Analysts favored growth and defensive sectors while showing caution toward consumer-sensitive areas.
Guggenheim kept a Buy rating on AppFolio, setting a $239 price target, a 10% upside from its Oct 22 close. The firm cited strong growth potential in real estate software and positive valuation adjustments.
UBS raised its price target for AppFolio from $220 to $240 while maintaining a neutral rating. The company's stock is currently trading at $205.18, down 5.59% over five days and 2.65% year-to-date. AppFolio reported Q3 2026 earnings on October 22, 2026.
via TradingView
APPF sentiment & insider activity
Recent APPF coverage spans financial news and earnings.
AlphAI scores every news story that mentions APPF with an AI model for sentiment and relevance, and aggregates insider trades from APPFOLIO INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Analysts updated ratings and price targets for various U.S. companies. Notable changes include downgrades for 10x Genomics (TXG) and upgrades for Allegion (ALLE). Price targets were raised for AbbVie (ABBV), Amgen (AMGN), and others, while cuts were seen in sectors like retail and housing. Analysts favored growth and defensive sectors while showing caution toward consumer-sensitive areas.
Guggenheim kept a Buy rating on AppFolio, setting a $239 price target, a 10% upside from its Oct 22 close. The firm cited strong growth potential in real estate software and positive valuation adjustments.
UBS raised its price target for AppFolio from $220 to $240 while maintaining a neutral rating. The company's stock is currently trading at $205.18, down 5.59% over five days and 2.65% year-to-date. AppFolio reported Q3 2026 earnings on October 22, 2026.
AppFolio's average price target increased to $246.14 from $244.71 by 7 analysts, with a range of $220-$280. This implies a 13% upside from the Oct. 22 closing price. The consensus rating remains 'Buy' among 11 analysts.
AppFolio (APPF) reported Q3 2026 revenue of $296M, up 19% YoY. CEO Shane Trigg noted non-GAAP operating income was 27.3% of revenue and GAAP operating income was 19.4%. The company anticipates 2026 revenue between $1.122B and $1.127B with a non-GAAP operating margin of 26.5%-27.5%.
APPFOLIO INC (APPF) filed an SEC Form 8-K — Results of Operations and Financial Condition. AppFolio, Inc. Announces Third Quarter 2026 Financial Results Consistency Continues with 19% Revenue Growth and Expanding Profitability SANTA BARBARA, Calif., October 22, 2026 -- AppFolio, Inc. (NASDAQ: APPF) ("AppFolio" or the "Company"), a technology leader powering the future
Keefe Bruyette raised its price target for AppFolio (NASDAQ:APPF) to $255 from $233, citing strong growth expectations. The firm anticipates a beat-and-raise quarter and higher-than-consensus revenue and earnings estimates. Other analysts have also revised their targets, with mixed outlooks on the stock's valuation and growth potential ahead of Q3 2026 earnings.
Citi upgraded Flutter (FLUT) to Buy with a $91 target. Cantor upgraded Humana (HUM) to Overweight with a $460 target. TD Cowen upgraded Marvell (MRVL) to Buy with a $350 target. Evercore upgraded NetApp (NTAP) to Outperform with a $300 target. Citi upgraded XPO (XPO) to Buy with a $224 target. UBS downgraded AppFolio (APPF) to Neutral with a $220 target. William Blair downgraded Option Care Health (OPCH) after its acquisition by CD&R and McKesson (MCK).
UBS downgraded AppFolio (APPF) to Neutral from Buy, citing slower unit growth and tougher market conditions due to interest rates and financing constraints, according to the firm. The company develops software for the U.S. real estate industry.
Wall Street analysts issued upgrades, downgrades, and initiations for several companies. Notable upgrades include Marvell (MRVL) to Buy with a $350 target and NetApp (NTAP) to Outperform with a $300 target. Downgrades include AppFolio (APPF) to Neutral with a $220 target. Initiations include Abbott Laboratories (ABT) with an Overweight rating and $120 target. Major indices closed at record highs, with the S&P 500 at 7,818 and Nasdaq at 27,599.